ArticleBMC bioinformatics2026
RiboZAP: a species-agnostic pipeline for rRNA depletion probe design in metatranscriptomics.
Article in BMC bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMetatranscriptomic (MetaT) sequencing provides insights into gene expression and functional activity within microbial communities, but its utility is limited by the high abundance of ribosomal RNA (rRNA), which often accounts for ≥ 90% of total RNA. Efficient rRNA depletion is therefore essential to maximize mRNA coverage and sequencing efficiency. Commercial rRNA depletion kits can effectively reduce rRNA content; they are typically optimized for specific host microbiomes and often underperform in others. For example, probes designed for the human gut microbiome frequently show reduced efficiency when applied to non-human samples such as mouse cecal donor samples-a common model in microbiome research. Regardless of the depletion strategy used, designing rRNA removal probes solely based on a microbiome's taxonomic composition often requires an extensive number of probes, making the approach expensive and difficult to manufacture. To address these challenges, we developed RiboZAP, a species-agnostic computational pipeline that designs custom RNase H depletion probes directly from MetaT sequencing data without prior knowledge of sample composition.
resultsRiboZAP-designed probe sets achieved 43-62% predicted rRNA depletion across both design and independent mouse cecal MetaT samples. Probes performed effectively on non-design samples, with depletion performance consistent with those observed in the design samples. Read composition and taxonomic diversity of residual rRNA, calculated using Shannon diversity indices, showed no evidence of probe-induced bias following depletion. In silico predictions were consistent with previously reported experimental depletion results [1-3], where RiboZAP designed probes improved mRNA recovery up to ~ 75% (P < 0.01). Comprehensive downstream validation demonstrated no bias in differential gene expression (R
conclusionIn this study, we demonstrate a data-driven, in silico approach for designing additional rRNA depletion probes that perform consistently across samples of the same sample type. Probe sets designed from a subset of samples can be applied to independent samples of the same type. This approach enables estimation of rRNA depletion prior to synthesis, reducing experimental costs, and improving the efficiency of MetaT profiling from complex microbial communities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.